Hutchmed Ltd. plans to file a second NDA in China for sovleplenib, a novel spleen tyrosine kinase inhibitor, based on positive phase II/III findings in warm antibody autoimmune hemolytic anemia.

Johnson & Johnson JNJ announced that the phase IIb JASMINE study, which evaluated its pipeline candidate, nipocalimab, for ...

Delivers rapid, durable responses in wAIHA, the more common form of this potentially life-threatening disease — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...

Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.

Introduction: Rates of temporary mechanical circulatory support (tMCS) have increased by more than 300% since FDA approval in the 1990s. With increased utilization, it is imperative for critical care ...

What Is Autoimmune Hemolytic Anemia? Autoimmune hemolytic anemia (AIHA) is a rare type of anemia that is diagnosed in only about 1-3 people per 100,000. Anemia is when your bone marrow doesn't make ...

Abstract: The aim of this study was to develop polyurethane (PU) wound dressing incorporated with cobalt nitrate using electrospinning technique. The morphology analysis revealed that the developed ...

Hemolysis is the #1 source of preanalytical error and can impact potassium results—potentially leading to inappropriate or delayed patient treatment, unnecessary ...

THIS report deals with an apparently unique case in which there was simultaneously selective red-cell aplasia of the bone marrow and an autoimmune hemolytic mechanism. The combination of continued ...

Microangiopathic hemolytic anemia (MAHA) occurs when turbulence in the blood destroys red blood cells. This leads to symptoms such as tiredness and shortness of breath. Certain treatments are ...

Enlargement of the left atrium, one of the heart’s upper chambers, is associated with a greater sickle cell disease (SCD) burden for patients, with more emergency department visits and blood test ...